Lindsley F. Kimball Research Institute (LFKRI)

LFKRI is the research branch of New York Blood Center. Since its establishment in 1964, LFKRI's research efforts have paved the way for new blood-related products, techniques and therapies and has resulted in numerous landmark patents and licenses.

People_IconCreated with Sketch.

Meet Our Investigators

LFKRI’s pioneering investigators have a remarkable depth of experience and expertise in their fields

Microscope_IconCreated with Sketch.

Areas of Research

Learn more about our areas of research

Beaker_IconCreated with Sketch.

Donate to Research

It takes more than blood to save a life

Research News

ExCellThera Enters into Agreement with CCS, a division of NYBC

This manufacturing and collaboration agreement covers the clinical grade production of ExCellThera’s lead cell therapy product, ECT-001.

Viral Immunology Lab Identifies Zika Subunit Vaccine

Zika virus remains a threat to public health due to its close association with microcephaly and other severe birth defects​.

Dr. Lanying Du Receives Her First NIH R01 Grant on MERS Vaccines

MERS-CoV, a newly emerging, highly pathogenic infectious virus, continues to threat public health worldwide with high mortality rate (about 35%).

Products & Services

We offer a comprehensive menu of services and products to support and manage the full spectrum of transfusion medicine, regenerative medicine and cellular-therapy related research projects, from basic science to full scale clinical trials.

About NYBC

New York Blood Center (NYBC) is one of the largest independent, community-based, nonprofit blood centers in the United States.